Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapies.
Kalathoor S, Ghazi S, Otieno B, Babcook MA, Chen S, Nidhi N, Bae J, Pierre-Charles J, Breathett K, Mazimba S, Johnson A, Brewer L, Mohammed S, Carter RR, Bonsu JM, Ferdousi M, Kola-Kehinde O, McLaughlin E, Brammer J, Ruz P, Khan S, Odei B, Mitchell D, Wei L, Patel P, Paskett ED, Addison D. Kalathoor S, et al. Among authors: kola kehinde o. Int J Cancer. 2024 Dec 1;155(11):1958-1968. doi: 10.1002/ijc.35110. Epub 2024 Aug 19. Int J Cancer. 2024. PMID: 39155749
Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation.
Gambril JA, Ghazi SM, Sansoterra S, Ferdousi M, Kola-Kehinde O, Ruz P, Kittai AS, Rogers K, Grever M, Bhat S, Wiczer T, Byrd JC, Woyach J, Addison D. Gambril JA, et al. Among authors: kola kehinde o. Leukemia. 2024 Oct;38(10):2141-2149. doi: 10.1038/s41375-024-02334-3. Epub 2024 Aug 17. Leukemia. 2024. PMID: 39154059 Free PMC article.
Comparison of atrial fibrillation prevalence and in-hospital cardiovascular outcomes between patients undergoing allogeneic versus autologous hematopoietic stem cell transplantation: insights from the national inpatient sample.
Krishan S, Asad ZUA, Quiroga D, Ghazi SM, Quartermaine C, Braunstein Z, Kola-Kehinde O, Shaaban A, Habib A, Khan S, Cheng R, Brammer JE, Addison D. Krishan S, et al. Among authors: kola kehinde o. Sci Rep. 2024 Jul 22;14(1):16829. doi: 10.1038/s41598-024-65294-9. Sci Rep. 2024. PMID: 39039091 Free PMC article.
Cardiovascular toxicities associated with bispecific T-cell engager therapy.
Sayed A, Munir M, Ghazi SM, Ferdousi M, Krishan S, Shaaban A, Habib A, Kola-Kehinde O, Ruz P, Khan S, Sharma S, Meara A, Mahmood S, Feldman S, Yang EH, Kim J, Epperla N, Addison D. Sayed A, et al. Among authors: kola kehinde o. J Immunother Cancer. 2024 Feb 21;12(2):e008518. doi: 10.1136/jitc-2023-008518. J Immunother Cancer. 2024. PMID: 38388168 Free PMC article.
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review.
Quartermaine C, Ghazi SM, Yasin A, Awan FT, Fradley M, Wiczer T, Kalathoor S, Ferdousi M, Krishan S, Habib A, Shaaban A, Kola-Kehinde O, Kittai AS, Rogers KA, Grever M, Ruz P, Bhat S, Dickerson T, Byrd JC, Woyach J, Addison D. Quartermaine C, et al. Among authors: kola kehinde o. JACC CardioOncol. 2023 Oct 17;5(5):570-590. doi: 10.1016/j.jaccao.2023.09.002. eCollection 2023 Oct. JACC CardioOncol. 2023. PMID: 37969643 Free PMC article. Review.
Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated Cardiotoxicity.
Buck B, Chum AP, Patel M, Carter R, Nawaz H, Yildiz V, Ruz P, Wiczer T, Rogers KA, Awan FT, Bhat S, Guha A, Kittai AS, Simonetti OP, Raman SV, Wallace G, Sanchez R, Bonsu JM, Gambril J, Haddad D, Mann J, Wei L, Kola-Kehinde O, Byrd JC, Woyach JA, Addison D. Buck B, et al. Among authors: kola kehinde o. JAMA Oncol. 2023 Apr 1;9(4):552-555. doi: 10.1001/jamaoncol.2022.6869. JAMA Oncol. 2023. PMID: 36729480 Free PMC article.
Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation.
Chen ST, Azali L, Rosen L, Zhao Q, Wiczer T, Palettas M, Gambril J, Kola-Kehinde O, Ruz P, Kalathoor S, Rogers K, Kittai A, Grever M, Awan F, Byrd JC, Woyach J, Bhat SA, Addison D. Chen ST, et al. Among authors: kola kehinde o. J Hematol Oncol. 2022 Jul 14;15(1):92. doi: 10.1186/s13045-022-01302-7. J Hematol Oncol. 2022. PMID: 35836241 Free PMC article.
Cardiovascular Event Reporting in Modern Cancer Radiation Therapy Trials.
Prasad RN, McIntyre M, Guha A, Carter RR, Yildiz VO, Paskett E, Lustberg M, Ruz P, Williams TM, Kola-Kehinde O, Miller ED, Addison D. Prasad RN, et al. Among authors: kola kehinde o. Adv Radiat Oncol. 2021 Dec 29;7(2):100888. doi: 10.1016/j.adro.2021.100888. eCollection 2022 Mar-Apr. Adv Radiat Oncol. 2021. PMID: 35198835 Free PMC article.
Diversity in modern heart failure trials: Where are we, and where are we going.
Anaba U, Ishola A, Alabre A, Bui A, Prince M, Okafor H, Kola-Kehinde O, Joseph JJ, Mitchell D, Odei BC, Uzendu A, Williams KP, Capers Q 4th, Addison D. Anaba U, et al. Among authors: kola kehinde o. Int J Cardiol. 2022 Feb 1;348:95-101. doi: 10.1016/j.ijcard.2021.12.018. Epub 2021 Dec 15. Int J Cardiol. 2022. PMID: 34920047 Free PMC article. Review.
12 results